Contact
searchSearch
HMP Global

Inflammatory Rheumatic Disorders

Exclusives

Research Summary
Fibromyalgia Creates High Global Burden of Depression and Anxiety
02/17/2026
Jessica Garlewicz
This first large-scale meta-analysis quantifies the substantial global prevalence of depression and anxiety in fibromyalgia patients, highlighting the need for integrated screening and holistic management approaches in clinical practice.
This first large-scale meta-analysis quantifies the substantial global prevalence of depression and anxiety in fibromyalgia patients, highlighting the need for integrated screening and holistic management approaches in clinical practice.
This first large-scale...
02/17/2026
Rheumatology & Arthritis
Clinical Trials
Bedtime Sublingual Cyclobenzaprine Improves Fibromyalgia Pain and Sleep
02/17/2026
Jessica Garlewicz
In fibromyalgia, nonrestorative sleep is closely linked to symptom severity.
In fibromyalgia, nonrestorative sleep is closely linked to symptom severity.
In fibromyalgia, nonrestorative...
02/17/2026
Rheumatology & Arthritis
News
Digital Psychological Intervention Improves Mental Health in Patients With Inflammatory Rheumatic Diseases
09/18/2025
Jessica Garlewicz
For rheumatologists, the findings suggest that digital mental health tools may serve as accessible, scalable adjuncts to traditional care, addressing the unmet psychological needs often seen in this patient population.
For rheumatologists, the findings suggest that digital mental health tools may serve as accessible, scalable adjuncts to traditional care, addressing the unmet psychological needs often seen in this patient population.
For rheumatologists, the...
09/18/2025
Rheumatology & Arthritis
News
Timing of IMID Diagnosis Influences Cancer Survival Outcomes, Study Finds
09/18/2025
Jessica Garlewicz
Recognizing whether an IMID predates or follows cancer diagnosis may guide clinical decisions regarding immunosuppression, surveillance, and therapy sequencing.
Recognizing whether an IMID predates or follows cancer diagnosis may guide clinical decisions regarding immunosuppression, surveillance, and therapy sequencing.
Recognizing whether an IMID...
09/18/2025
Rheumatology & Arthritis
News
Oral Opioid Use Linked to Increased Mortality in Inflammatory Arthritis, National Cohort Study Shows
07/10/2025
Jessica Garlewicz
Clinicians should consider routine review of opioid use in IA care plans and explore adjunctive approaches.
Clinicians should consider routine review of opioid use in IA care plans and explore adjunctive approaches.
Clinicians should consider...
07/10/2025
Rheumatology & Arthritis
News
International Delphi Study Identifies Top Research Priorities for Musculoskeletal Health in Joint Hypermobility
06/24/2025
Jessica Garlewicz
This study underscores the pressing need for evidence-based approaches to managing musculoskeletal complications of GJH.
This study underscores the pressing need for evidence-based approaches to managing musculoskeletal complications of GJH.
This study underscores the...
06/24/2025
Rheumatology & Arthritis
Research Highlights
Certolizumab Pegol Reduces Adverse Pregnancy Outcomes in High-Risk APS Patients
06/24/2025
Jessica Garlewicz
The results support further investigation of TNF-α inhibition as a strategy to improve maternal and neonatal outcomes in this high-risk cohort.
The results support further investigation of TNF-α inhibition as a strategy to improve maternal and neonatal outcomes in this high-risk cohort.
The results support further...
06/24/2025
Rheumatology & Arthritis
News
CE-DECT Demonstrates High Diagnostic Utility in Inflammatory Arthritis of the Hand
06/10/2025
Jessica Garlewicz
CE-DECT imaging results led to a change in diagnosis in nearly half the cases (49.2%), underscoring the method’s influence on clinical decision-making.
CE-DECT imaging results led to a change in diagnosis in nearly half the cases (49.2%), underscoring the method’s influence on clinical decision-making.
CE-DECT imaging results led to a...
06/10/2025
Rheumatology & Arthritis
Dacre Knight
Podcast
Dacre Knight, MD, on Hypermobility
04/30/2025
Dacre Knight, MD
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo...
04/30/2025
Rheumatology & Arthritis
News
Guideline Recommendations for DMARD Use in Pregnancy Show Significant Variability
04/29/2025
Jessica Garlewicz
The review evaluated 18 guidelines published since 2014 from academic rheumatology societies, focusing on rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and systemic lupus erythematosus.
The review evaluated 18 guidelines published since 2014 from academic rheumatology societies, focusing on rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and systemic lupus erythematosus.
The review evaluated 18...
04/29/2025
Rheumatology & Arthritis
News
Psychiatric Misdiagnoses Linked to Long-Term Harm in Patients With Autoimmune Rheumatic Diseases
04/17/2025
Jessica Garlewicz
Researchers analyzed data using validated mental health measures and patient-designed questions to assess depression, anxiety, mental wellbeing, and healthcare behaviors.
Researchers analyzed data using validated mental health measures and patient-designed questions to assess depression, anxiety, mental wellbeing, and healthcare behaviors.
Researchers analyzed data using...
04/17/2025
Rheumatology & Arthritis

Q&As

Q&As
Laura Plantinga, PhD, on Cognitive Assessments Among Patients With SLE
07/19/2021
Laura Plantinga, PhD, from Emory University in Atlanta, Georgia, and colleagues conducted a pilot study to investigate the utility of the National Institutes of Health Toolbox in assessing cognition among patients with SLE.
Laura Plantinga, PhD, from Emory University in Atlanta, Georgia, and colleagues conducted a pilot study to investigate the utility of the National Institutes of Health Toolbox in assessing cognition among patients with SLE.
Laura Plantinga, PhD, from Emory...
07/19/2021
Rheumatology & Arthritis
infusion with gloved hand
Q&As
Rita Machado, MD, on bDMARDS and axSpA Remission
02/05/2021
A team of researchers sought to determine whether treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) showed efficacy among patients with axial spondyloarthritis (axSpA) in achieving Assessment of...
A team of researchers sought to determine whether treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) showed efficacy among patients with axial spondyloarthritis (axSpA) in achieving Assessment of...
A team...
02/05/2021
Rheumatology & Arthritis
Q&As
4 Questions About Self-Management Education in Patients With Rheumatic Diseases
04/27/2020
Self-management education programs are implemented to help reduce symptoms and improve quality of life among patients with chronic health conditions, such as rheumatoid arthritis. The programs can be implemented at the...
Self-management education programs are implemented to help reduce symptoms and improve quality of life among patients with chronic health conditions, such as rheumatoid arthritis. The programs can be implemented at the...
...
04/27/2020
Rheumatology & Arthritis
Q&As
5 Questions About the DASH Diet and Hyperuricemia
04/01/2020
Several nutrients and foods are associated with uric acid status. However, the association between overall diet quality and hyperuricemia is unclear. A research team led by Yun Gao, MD, and Xiang Gao, MD, PhD, aimed to...
Several nutrients and foods are associated with uric acid status. However, the association between overall diet quality and hyperuricemia is unclear. A research team led by Yun Gao, MD, and Xiang Gao, MD, PhD, aimed to...
Several...
04/01/2020
Rheumatology & Arthritis
Q&As
6 Questions About the Medical and Support Needs of Men With SLE
03/04/2020
Men with systemic lupus erythematosus (SLE) seek medical attention and supportive care for their condition less than women. Additionally, data on the medical, psychosocial, and support needs of men with SLE are...
Men with systemic lupus erythematosus (SLE) seek medical attention and supportive care for their condition less than women. Additionally, data on the medical, psychosocial, and support needs of men with SLE are...
Men with...
03/04/2020
Rheumatology & Arthritis
Q&As
5 Questions About the G-CAN Consensus Statement on New Gout Terminology
02/20/2020
The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) has developed a consensus statement regarding the labels and definitions used for disease states of gout. G-CAN sought to overcome...
The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) has developed a consensus statement regarding the labels and definitions used for disease states of gout. G-CAN sought to overcome...
...
02/20/2020
Rheumatology & Arthritis
Q&As
5 Questions About IBS and Axial Spondyloarthritis
01/28/2020
More than half of all patients with ankylosing spondylitis (AS) report frequent gut pain and diarrhea. However, while microscopic gut inflammation is common in this disease, such inflammation has not been clearly...
More than half of all patients with ankylosing spondylitis (AS) report frequent gut pain and diarrhea. However, while microscopic gut inflammation is common in this disease, such inflammation has not been clearly...
More...
01/28/2020
Rheumatology & Arthritis
Q&As
5 Questions About Cardiovascular Risk and NSAID Use in Ankylosing Spondylitis
10/23/2019
Nonsteroidal anti‐inflammatory drugs (NSAIDs) increase blood pressure and potential cardiovascular burden, but what is the association between NSAID use and incident hypertension in ankylosing spondylitis (AS)? To...
Nonsteroidal anti‐inflammatory drugs (NSAIDs) increase blood pressure and potential cardiovascular burden, but what is the association between NSAID use and incident hypertension in ankylosing spondylitis (AS)? To...
...
10/23/2019
Rheumatology & Arthritis
Alexis Ogdie, MD
Q&As
Alexis Ogdie, MD, on Achieving Minimal Disease Activity Among Patients With PsA
10/04/2023
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions...
10/04/2023
Rheumatology & Arthritis
Dr Ching-Lung Cheung
Q&A
Ching-Lung Cheung, PhD, on the Health Burden of Osteoporotic Fractures Among the Aging Population
09/29/2023
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few...
09/29/2023
Rheumatology & Arthritis
Monica Schwartzman
Q&A
Monica Schwartzman, MD, on Medication Preferences Among Patients With PsA
08/21/2023
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our...
08/21/2023
Rheumatology & Arthritis
Lars Klareskog, MD
Q&A
Lars Klareskog, MD, on the Study of Occupational Exposures and Risk of RA
08/08/2023
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a...
08/08/2023
Rheumatology & Arthritis
Yassein Shamout, MD, FRCPC, DABD
Q&As
Optimizing Patient Care: Collaboration Between Dermatology and Rheumatology
06/20/2023
Jessica Garlewicz
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in...
06/20/2023
The Dermatologist
Jennifer L Barton, MD, MCR
Q&As
Jennifer L Barton, MD, on Goal Elicitation for Patients with RA
01/06/2023
In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.
In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.
In this Q&A, Dr. Barton...
01/06/2023
Rheumatology & Arthritis
Saundra Jain
Q&A
Wellness in Rheumatic Diseases: A Conversation with Saundra Jain, MS, PsyD, and Andrew Laster, MD
09/30/2022
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS,...
09/30/2022
Rheumatology & Arthritis
Dana Villmore
Q&A
Dana Villmore, PhD, Pa-C, on Treating Fibromyalgia in a Primary Care Setting
07/20/2022
In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.
In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.
In this Q&A, Dana Villmore, PhD,...
07/20/2022
Rheumatology & Arthritis
Betty Hsaio
Q&A
Betty Hsiao, MD, on Patient Conceptualization of RA Treatment
07/19/2022
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale...
07/19/2022
Rheumatology & Arthritis
Alexis Ogdie
Q&A
Alexis Ogdie, MD, on a Treat To Target Approach to Psoriatic Arthritis
06/29/2022
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving minimal disease activity for patients with psoriatic arthritis? Alexis Ogdie, MD, of the University of Pennsylvania, answers some questions about her research into this subject in this Q&A.
How beneficial is achieving...
06/29/2022
Rheumatology & Arthritis

Podcasts

Dacre Knight
Podcast
Dacre Knight, MD, on Hypermobility
04/30/2025
Dacre Knight, MD
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo...
04/30/2025
Rheumatology & Arthritis
Leonard Calabrese, DO
Podcast
Drs Alfred Kim and Leonard Calabrese on Long COVID Among Immunosuppressed Patients
03/06/2023
In this podcast, Alfred Kim, MD, PhD, and Leonard Calabrese, DO, provide updates on the rapidly changing dynamics of long COVID. They also discuss current strategies in managing the lingering effects after COVID-19 infection among the...
In this podcast, Alfred Kim, MD, PhD, and Leonard Calabrese, DO, provide updates on the rapidly changing dynamics of long COVID. They also discuss current strategies in managing the lingering effects after COVID-19 infection among the...
In this podcast, Alfred Kim, MD,...
03/06/2023
Rheumatology & Arthritis
Sparks head shot
Podcast
Jeffrey Sparks, MD, MMSC, and Alfred Kim, MD, PhD, on COVID-19 Vaccines for Patients With RMDs
11/03/2021
In this podcast, rheumatologists Jeffrey Sparks, MD, and Alfred Kim, MD, discuss how recent developments in COVID-19 vaccine research and policy may affect patients with rheumatic and musculoskeletal diseases.
In this podcast, rheumatologists Jeffrey Sparks, MD, and Alfred Kim, MD, discuss how recent developments in COVID-19 vaccine research and policy may affect patients with rheumatic and musculoskeletal diseases.
In this podcast, rheumatologists...
11/03/2021
Rheumatology & Arthritis
Podcasts
W. Benjamin Nowell, PhD, on PROs Using the ArthritisPower App
03/10/2021
In this podcast, W. Benjamin Nowell, PhD, Director, Patient-Centered Research at CreakyJoints and principal investigator of ArthritisPower discusses the newly published study,“Which patient-reported outcomes do rheumatology patients find...
In this podcast, W. Benjamin Nowell, PhD, Director, Patient-Centered Research at CreakyJoints and principal investigator of ArthritisPower discusses the newly published study,“Which patient-reported outcomes do rheumatology patients find...
In this podcast, W. Benjamin...
03/10/2021
Rheumatology & Arthritis
RHEUMATOLOGY
Lisa Sammaritano, MD, on the New ACR Guideline for Managing Reproductive Health
05/11/2020
She talks about the ACR’s new guideline on reproductive health, including how you can help patients make decisions about contraception and choose appropriate medications during pregnancy.
She talks about the ACR’s new guideline on reproductive health, including how you can help patients make decisions about contraception and choose appropriate medications during pregnancy.
She talks about the ACR’s new...
05/11/2020
Rheumatology & Arthritis
RHEUMATOLOGY
J. Antonio Aviña-Zubieta, MD, MSc, PhD, on Venous Thromboembolism in Gout
04/15/2020
He discusses his research on the overall risk and temporal trends of venous thromboembolism, deep vein thrombosis, and pulmonary embolism in patients with gout.
He discusses his research on the overall risk and temporal trends of venous thromboembolism, deep vein thrombosis, and pulmonary embolism in patients with gout.
He discusses his research on the...
04/15/2020
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
05/11/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
05/11/2026
Rheumatology & Arthritis
Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/11/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/11/2026
Rheumatology & Arthritis
Shikha Singla
Expert Insights
Shikha Singla, MD, on Comparative Analysis of Guidelines for PsA
05/10/2026
Shikha Singla, MD
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the...
05/10/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA: Part 2
04/30/2026
Philip Mease, MD
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of...
04/30/2026
Rheumatology & Arthritis
Philip Mease
Expert Insights
Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA
04/23/2026
Philip Mease, MD
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast,...
04/23/2026
Rheumatology & Arthritis
Expert Insights
Daniel Solomon, MD, on Treat to Target vs Symptoms in Gout
02/04/2026
Daniel Hal Solomon, MD
In this podcast, Dr Solomon reviews the design of, recruitment for, and established outcomes of the TRUST trial, a randomized controlled active comparator strategy for gout to compare a treat to target serum urate strategy versus an approach...
In this podcast, Dr Solomon reviews the design of, recruitment for, and established outcomes of the TRUST trial, a randomized controlled active comparator strategy for gout to compare a treat to target serum urate strategy versus an approach...
In this podcast, Dr Solomon...
02/04/2026
Rheumatology & Arthritis
Dacre Knight
Podcast
Dacre Knight, MD, on Hypermobility
04/30/2025
Dacre Knight, MD
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo...
04/30/2025
Rheumatology & Arthritis
Len Calabrese
Podcast
Leonard Calabrese, DO, on Long COVID Similarities to Fibromyalgia, ME/CFS
01/02/2025
Leonard Calabrese, DO
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the...
01/02/2025
Rheumatology & Arthritis
Misti Paudel
Podcast
Misti Paudel, PhD, on Difficult-to-Treat Rheumatoid Arthritis
08/12/2024
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she...
08/12/2024
Rheumatology & Arthritis
Vikas Majithia
Podcast
Vikas Majithia, MD, and Ronald Butendieck, MD, on the Continuing Challenges of Gout
06/20/2024
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck...
06/20/2024
Rheumatology & Arthritis

Quizzes

Quiz
Body Mass Index and the Risk of Rheumatic Diseases
03/14/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Is obesity a risk and severity...
03/14/2024
Rheumatology & Arthritis
laptop+coffee+working+relax time
Quiz
Adalimumab and Biosimilar
09/21/2022
Would switching from reference adalimumab to a biosimilar have any impact on disease activity or adverse effects among patients with inflammatory rheumatic joint diseases? Take our quiz to find out!
Would switching from reference adalimumab to a biosimilar have any impact on disease activity or adverse effects among patients with inflammatory rheumatic joint diseases? Take our quiz to find out!
Would switching from reference...
09/21/2022
Rheumatology & Arthritis
A doctor taking notes
Quiz
Quiz: Is Proactive Therapeutic Drug Monitoring Superior to Standard Treatment?
08/08/2022
In a recent clinical trial, researchers compared therapeutic drug monitoring during maintenance infliximab therapy with standard treatment. Which therapy was more likely to lead to sustained disease control among patients with immune-mediated...
In a recent clinical trial, researchers compared therapeutic drug monitoring during maintenance infliximab therapy with standard treatment. Which therapy was more likely to lead to sustained disease control among patients with immune-mediated...
In a recent clinical trial,...
08/08/2022
Rheumatology & Arthritis
injection
Quiz
RMD Therapies and COVID-19 Vaccines
08/02/2022
Rebecca Mashaw
Many therapeutic agents for rheumatic and musculoskeletal diseases suppress the immune system in patients. Which of these agents is most likely to also cause patients not to mount a significant response to vaccines, including the vaccine for...
Many therapeutic agents for rheumatic and musculoskeletal diseases suppress the immune system in patients. Which of these agents is most likely to also cause patients not to mount a significant response to vaccines, including the vaccine for...
Many therapeutic agents for...
08/02/2022
Rheumatology & Arthritis
A vaccine
Quiz
Predictors of Influenza Vaccine Hesitancy
03/31/2022
Researchers recently investigated influenza vaccine hesitancy among rheumatology patients. Do you know which issues were the biggest contributors?
Researchers recently investigated influenza vaccine hesitancy among rheumatology patients. Do you know which issues were the biggest contributors?
Researchers recently...
03/31/2022
Rheumatology & Arthritis
Quiz
Pop Quiz: Recommendations for Treating AS and SpA
06/16/2020
In its recently updated guidelines for the treatment of ankylosing spondylitis (AS) or nonradiographic axial spondyloarthritis (SpA) the American College of Rheumatology, Spondylitis Association of America, and...
In its recently updated guidelines for the treatment of ankylosing spondylitis (AS) or nonradiographic axial spondyloarthritis (SpA) the American College of Rheumatology, Spondylitis Association of America, and...
In...
06/16/2020
Rheumatology & Arthritis
Quiz
Pop Quiz: ACR Guideline on the Treatment of Gout
06/01/2020
Despite recommendations from the American College of Rheumatology (ACR) and other international societies, the use of treat‐to‐target strategies with urate‐lowering therapy (ULT) has not increased over the past 20...
Despite recommendations from the American College of Rheumatology (ACR) and other international societies, the use of treat‐to‐target strategies with urate‐lowering therapy (ULT) has not increased over the past 20...
...
06/01/2020
Rheumatology & Arthritis
Quiz
Pop Quiz: Recommendations for Treating Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
05/26/2020
Some patients with ankylosing spondylitis (AS) or nonradiographic axial spondyloarthritis (SpA) do not receive adequate relief from nonsteroidal anti-inflammatory drugs (NSAIDs). In these cases, the updated...
Some patients with ankylosing spondylitis (AS) or nonradiographic axial spondyloarthritis (SpA) do not receive adequate relief from nonsteroidal anti-inflammatory drugs (NSAIDs). In these cases, the updated...
Some...
05/26/2020
Rheumatology & Arthritis
Quiz
Quiz: COVID-19 and Inflammatory Rheumatic Diseases
04/10/2000

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Is there a connection between the SARS-CoV-2 infection and inflammatory rheumatic diseases? Find out with a pop test!
Is there a connection between the SARS-CoV-2 infection and inflammatory rheumatic diseases? Find out with a pop test!
Is there a connection between...
04/10/2000
Rheumatology & Arthritis
Quiz
Quiz: Gout Management Goals
04/10/2000

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Do you know what the long-term goals of gout management among older patients include? Take our quick quiz to find out!
Do you know what the long-term goals of gout management among older patients include? Take our quick quiz to find out!
Do you know what the long-term...
04/10/2000
Rheumatology & Arthritis
Quiz
Progression from PsO to PsA
04/28/2026
Rebecca Mashaw
Do you know which patients with psoriasis are most at risk of progression to psoriatic arthritis? Take our quick quiz to find out!
Do you know which patients with psoriasis are most at risk of progression to psoriatic arthritis? Take our quick quiz to find out!
Do you know which patients with...
04/28/2026
Rheumatology & Arthritis
Quiz
Treat-to-Target vs Symptom-Based Gout Care: What’s the Difference?
04/01/2026
Riya Gandhi, MA
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout management strategies by comparing serum urate treat-to-target approaches with symptom-guided care. This quiz highlights key clinical principles shaping modern gout treatment and long-term disease control.
Test your understanding of gout...
04/01/2026
Rheumatology & Arthritis
Quiz
Why Flare Frequency Matters in Clinical Trials
04/01/2026
Riya Gandhi, MA
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency remains a key primary outcome in clinical trials despite the disease’s chronic and erosive nature. This quiz reinforces outcome selection and trial design principles in gout research.
Explore why gout flare frequency...
04/01/2026
Rheumatology & Arthritis
Quiz
Hyperuricemia vs Gout: Understanding the Clinical Relationship
04/01/2026
Riya Gandhi, MA
Test your knowledge of the relationship between hyperuricemia and clinical gout. This quiz clarifies key distinctions that impact diagnosis, risk assessment, and treatment decisions in rheumatology practice.
Test your knowledge of the relationship between hyperuricemia and clinical gout. This quiz clarifies key distinctions that impact diagnosis, risk assessment, and treatment decisions in rheumatology practice.
Test your knowledge of the...
04/01/2026
Rheumatology & Arthritis
Quiz
Pegloticase + Methotrexate: What Rising Uric Acid Means
04/01/2026
Riya Gandhi, MA
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of pegloticase therapy by interpreting rising serum urate levels in combination treatment protocols. This quiz highlights key monitoring principles and response criteria from the AGILE trial.
Assess your understanding of...
04/01/2026
Rheumatology & Arthritis
Quiz
Sex-Based Differences in Response to Advanced Therapies in Axial Spondyloarthritis
08/07/2025
Rebecca Mashaw
Do men or women achieve better outcomes with advanced therapies for axial spondyloarthritis? Find out by taking our quick quiz.
Do men or women achieve better outcomes with advanced therapies for axial spondyloarthritis? Find out by taking our quick quiz.
Do men or women achieve better...
08/07/2025
Rheumatology & Arthritis
Quiz
What Factor Increases Mortality in Rheumatoid Arthritis?
08/07/2025
Rebecca Mashaw
One factor showed a substantial association with mortality among patients with rheumatoid arthritis. Find out what it is with our quiz!
One factor showed a substantial association with mortality among patients with rheumatoid arthritis. Find out what it is with our quiz!
One factor showed a substantial...
08/07/2025
Rheumatology & Arthritis
Quiz
How to Assess Frailty in SLE
07/21/2025
Rebecca Mashaw
07/21/2025
Rheumatology & Arthritis
Quiz
Continuation of Therapy With bDMARDs vs JAKs in RA
07/21/2025
Rebecca Mashaw
07/21/2025
Rheumatology & Arthritis
Quiz
NSAIDs and axSpA
08/30/2024
Riya Gandhi, MA
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Is there any association between...
08/30/2024
Rheumatology & Arthritis

Popular Articles

Misti Paudel
Podcast
Misti Paudel, PhD, on Difficult-to-Treat Rheumatoid Arthritis
08/12/2024
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she...
08/12/2024
Rheumatology & Arthritis
News
Serum Biomarkers Linked With IBD-Associated axSpA
09/23/2024
Jolynn Tumolo
The genetic variant NOD2/CARD15 polymorphism appears related to subclinical intestinal inflammation in patients with axial spondyloarthritis.
The genetic variant NOD2/CARD15 polymorphism appears related to subclinical intestinal inflammation in patients with axial spondyloarthritis.
The genetic variant NOD2/CARD15...
09/23/2024
Rheumatology & Arthritis
News
Subcutaneous Ustekinumab Cost Rose 84% Under Medicare Part D, Set to Drop Under Negotiated Price Reduction
08/15/2024
Rebecca Mashaw
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted...
08/15/2024
Rheumatology & Arthritis
FDA Alert
FDA Approves Bimekizumab for PsA, nr-axSpA and AS
09/23/2024
Rebecca Mashaw
Already approved for plaque psoriasis, bimekizumab is designed to selectively inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F).
Already approved for plaque psoriasis, bimekizumab is designed to selectively inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F).
Already approved for plaque...
09/23/2024
Rheumatology & Arthritis
News
Ultraprocessed Food Intake and SLE Incidence Among Women
07/12/2024
Jessica Garlewicz
Sugar- and artificially sweetened-beverages were among the key contributors to heightened risk of developing systemic lupus erythematosus.
Sugar- and artificially sweetened-beverages were among the key contributors to heightened risk of developing systemic lupus erythematosus.
Sugar- and artificially...
07/12/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use